Human tissue urokinase-type plasminogen activator

Drug Profile

Human tissue urokinase-type plasminogen activator

Alternative Names: HTUPA

Latest Information Update: 10 Aug 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Wyeth
  • Class Plasminogen activator enzymes
  • Mechanism of Action Plasminogen activators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Myocardial infarction; Stroke

Most Recent Events

  • 10 Aug 2009 Discontinued - Phase-I/II for Myocardial infarction in Taiwan (Parenteral)
  • 10 Aug 2009 Discontinued - Phase-I/II for Stroke in Taiwan (Parenteral)
  • 11 Aug 2004 Phase-I/II clinical trials in Myocardial infarction in Taiwan (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top